At a glance
ClinicalIndex Comparison RecordN/ACompleted· 52 enrolled
Drug / intervention
Spirulina +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effects of Spirulina Supplementation on Anthropometric Measurements, Lipid Profile, Appetite, Liver Enzymes, Inflammatory and Glycemic Markers on Overweight or Obese Adults
Shahid Beheshti University of Medical Sciences·interventional·Posted Dec 15, 2016·Updated Apr 11, 2019
In Brief
A clinical study evaluating Spirulina and diet therapy for Obesity. Completed, enrolled 52 participants across 1 site.
Detailed Summary
In this double-blind Randomized Controlled Clinical Trial investigators are going to study the effects of Spirulina supplementation on anthropometric measurements, lipid profile, appetite, liver enzymes, inflammatory and glycemic markers in a sample of overweight or obese adults.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsObesity
CountriesIran
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
Enrollment StartDec 2016
First PostedDec 2016
Primary CompletionJul 2017
Study CompletionDec 2017
TodayJul 2026
First PostedDec 15, 2016
Enrollment StartDec 1, 2016
Primary CompletionJul 1, 2017
Study CompletionDec 1, 2017
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 9.5 years ago
Interventions
Spirulinadietary
2 g(4\* 500 mg tablets) daily intake of Spirulina Platensis
diet therapyother
low calorie diet (-500 or -300 kcal) composed of 55% carbohydrate, 15% protein and 30% fat